Glaucoma Research Society of Canada   Report issue

Academic/Hospital Phase 4
Founded: Toronto Canada (1997)

Organization Overview

First Clinical Trial
2007
NCT00485108
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Glaucoma Research Society of Canada

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glaucoma (Phase 4)

Optic Nerve Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 8